// App-Quantinova.ai

EP1126 : EFFECTIVENESS OF ROMIPLOSTIM ON PLATELET ENDPOINTS AMONG PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA IN ROUTINE CLINICAL PRACTICE IN DENMARK, SWEDEN, AND NORWAY

Researchers

Presenter

  • Christian Fynbo Christiansen

Principal Investigators

  • Nickolaj Risbo

  • Waleed Ghanima

  • Marie Linder

  • Shahram Bahmanyar

  • Anouchka Seesaghur

  • Mary Clouser

  • Mette Nrgaard

  • Henrik Toft Srensen

Medical Centers

  • Centre for Pharmacoepidemiology, Department of Medicine,Karolinska Institutet,Stockholm,Sweden

  • Clinical Epidemiology Division &amp

  • Department of Clinical Epidemiology,Aarhus University Hospital,Aarhus N,Denmark

  • Department of Medicine,Østfold Hospital Trust,Kalnes,Noruega

  • Department of Rheumatology, Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway

  • Center for Observational Research,Amgen,Thousand Oaks,United States

  • Centre for Observational Research,Amgen Ltd.,Uxbridge,United Kingdom

Locations

  • Sweden

  • Denmark

  • Norway

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Romiplostim

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved